相关实验视频

Updated: Jun 26, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

部分切除术是T1b细胞癌患者的主要选择 - - 一项基于全国人口的研究

Sven Lundstam¹, Tarik Almdalal², Andreas Karlsson Rosenblad^3,4,5,6

¹Departments of Urology and Oncology, University of Gothenburg Sahkgrenska Academy, Gothenburg, Sweden.

Urology research & practice

|April 17, 2025

概括

部分切除术 (PN) 对于临床T1b细胞癌 (RCC) 不逊于激进切除术 (RN). 这支持提供PN,尽管在RCC患者中存在升级和复发的风险.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
在瘤学瘤学.
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

临床T1细胞癌 (RCC) 一般具有良好的预后.
部分切除术 (PN) 建议用于cT1b RCC,但升级和复发的风险引发了对其偏好的疑问.
描述临床和形态变量以及整体存活率 (OS) 对cT1b RCC管理至关重要.

研究的目的:

评估非转移性cT1b RCC患者的全国真实世界人口中的临床和形态变量和整体存活率 (OS).
为了比较部分切除术 (PN) 与激进切除术 (RN) 在这个患者队列中的结果.
评估cT1b RCC患者上升阶段和疾病复发的风险.

主要方法:

利用来自瑞典国家癌登记 (2005-2014) 的数据,对2006年非转移性cT1b RCC患者进行了至少5年的随访.
评估了患者的人口统计,瘤特征 (大小,类型),手术方法 (PN与RN),升级到pt3a,局部/远程复发和整体存活率 (OS).
进行调整分析以确定与复发风险和OS相关的因素,并将PN与RN结果进行比较.

主要成果:

在2006年患者中,15%的患者升级到pT3a,16%的患者出现疾病复发.
在PN和RN之间没有观察到复发率的显著差异.
与pT1b (83%) 相比,pT3a RCC患者的5年生存率 (67%) 显著降低. 经过调整后的分析显示,PN不低于RN (HR 0.91).

结论:

临床T1b RCC患者面临着升级,复发和OS降低的显著风险.
在经过调整的分析中,部分切除术 (PN) 证明与彻底切除术 (RN) 不相差.
这些发现支持继续推和提供针对cT1b RCC的PN.

关键词:

这是一个RCC类型的RCC类型.cT1bb 在线观看 pT1bb 这是一个很好的方法.部分脏切除术部分脏切除术进行激进性切除术.细胞癌瘤是细胞癌.幸存率幸存率生存率瘤的大小瘤大小瘤的阶段瘤的阶段

更多相关视频

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

相关概念视频

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...